home.aspx
 
EVENTS

2nd Middle East Pharmacy and Pharmaceutical Conference
2ND MIDDLE EAST PHARMACY AND PHARMACEUTICAL CONFERENCE
December 09-10, 2019
The 2nd Middle east Pharmacy and Pharmaceutical Conference will be held amid December 09-10, 2019 at Dubai, UAE.  Pharma Conference 2019 is a worldwide stage for drug specialists, pharmaceutical advertising professional's, pharmaceutical industry experts, and analysts, researchers, clinicia...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

Care UK

Care UK have been delivering health and social care services throughout the UK for more than 30 years with our experts working across more types of care services than any other organisation in the UK. We are an award winning company who is one of the UKs largest independent provider to the NHS and we work together to take healthcare services closer to where people live and work – increasing the efficiency and quality of the services we deliver and helping to reduce waiting times. Our healthcare services include treatment centres, GP practices, NHS walk-in centres, GP out-of-hours, prison health services, NHS 111 and clinical assessment and diagnostics facilities.

RELATED NEWS


The United States is battling an opioid crisis, and it is critically important that healthcare organizations do what they can to identify patients at high risk of suffering from the negative effects of this form of pain management. One organization addressing this issue is Commonwealth Care Alliance (CCA), a not-for-profit healthcare organization that serves more than 32,000 low-income, disabled, and elderly patients across Massachusetts who are dually eligible for Medicare and Medicaid. These i...

READ MORE

TraceLink, an integrated digital supply network, announces the launch of the Digital Network Platform. Built on top of the TraceLink Digital Supply Network, and designed for the rapid development of applications utilizing its multi-enterprise collaboration and data sharing capabilities, TraceLink’s Digital Network Platform is meant to drive innovation and enable the creation of new supply chain operating models centered around the patient. The TraceLink network is used to track serialized ...

READ MORE

Medicare and its beneficiaries could have saved an estimated $17.7 billion over a seven-year period on generic versions of older medicines instead of paying for newer, chemically similar but more expensive brand-name drugs, according to a study published in the Annals of Internal Medicine last month. The study was conducted as part of the Collaboration for Research Integrity and Transparency at Yale Law School, funded by the Laura and John Arnold Foundation. The intent was to estimate the potent...

READ MORE

As Democratic presidential primary candidates try to walk a political tightrope between the party’s progressive and center-left wings, they face increasing pressure to outline the details of their health reform proposals. On Wednesday, Sen. Bernie Sanders (I-Vt.) reaffirmed his stance by reintroducing a “Medicare-for-all” bill, the idea that fueled his 2016 presidential run. As with its previous iterations, Sanders’ latest bill would establish a national single-payer &ldq...
KHN
READ MORE

The U.S. Food and Drug Administration on Tuesday approved a new generic of heart medicine Valsartan and said it prioritized the drug's review to help relieve recent shortage as manufacturers around the world have pulled the treatment from the market. Several drugmakers, including Teva Pharmaceutical Industries Ltd and Mylan NV, have recalled batches of Valsartan as the drugs have been found to contain probable carcinogens. The approval of the generic, Diovan, was granted to Alkem Laboratorie...

READ MORE

An allergic reaction of any kind is a result of the immune system responding to an otherwise harmless allergen as if it were a pathogen. However, sending the right messages to the immune system can change the way it operates, as Duke University scientists found in their new study aimed at reducing the severity of food allergies....
LABROOT
READ MORE

ViiV Healthcare’s Juluca has been green-lighted in the US as the first two-drug regimen for some patients with HIV. Juluca is comprised of ViiV’s dolutegravir, an integrase strand transfer inhibitor, and Janssen’s rilpivirine 25mg, a non-nucleoside reverse transcriptase inhibitor....

READ MORE

It is looking unlikely that patients in England and Wales with advanced renal cell carcinoma will be getting routine NHS access to Eisai’s Kisplyx or Eusa Pharma’s Fotivda, after cost regulators issued draft guidelines turning down their use. The National Institute for Health and Care Excellence said it is not recommending NHS funding for Kisplyx (lenvatinib) in combination with everolimus for previously treated patients because of uncertainties in the clinical evidence. While trial data suggest...

READ MORE

A long-acting, two-drug HIV regimen being co-developed by ViiV Healthcare and Janssen Sciences Ireland UC has shown comparable viral suppression rates to a three-drug regimen in a Phase II trial, indicating its potential to reduce the dosing burden for patients and thus improve treatment adherence. The LATTE-2 study assessed long-acting, injectable formulations of cabotegravir (ViiV) and rilpivirine (Janssen, branded Edurant), given every four or eight weeks to patients with HIV-1 infection who ...

READ MORE

Aspen Pharmacare Holdings Ltd. faces a European Union antitrust probe for ramping up the price of cancer drugs as the EU joins a global crackdown on the soaring cost of life-saving generic medicines....

READ MORE

EVENTS

2nd Middle East Pharmacy and Pharmaceutical Conference
2ND MIDDLE EAST PHARMACY AND PHARMACEUTICAL CONFERENCE
December 09-10, 2019
The 2nd Middle east Pharmacy and Pharmaceutical Conference will be held amid December 09-10, 2019 at Dubai, UAE.  Pharma Conference 2019 is a worldwide stage for drug specialists, pharmaceutical advertising professional's, pharmaceutical industry experts, and analysts, researchers, clinicia...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...